Clozapine counteracts a ketamine-induced depression of hippocampal-prefrontal neuroplasticity and alters signaling pathway phosphorylation

• Marion Rame,

  Affiliations Laboratoire de Physiopathologie des Maladies Psychiatriques, UMR_S894 Inserm, Centre de Psychiatrie et Neurosciences, Paris, France, Université Paris Descartes, Sorbonne Paris Cité, Paris, France

  ⨯
• Dorian Caudal,

  Affiliation Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden

  ⨯
• Esther Schenker,

  Affiliation Institut de Recherches Servier, Croissy-sur-Seine, France

  ⨯
• Per Svenningsson,

  Affiliation Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden

  ⨯
• Michael Spedding,

  Affiliations Institut de Recherches Servier, Croissy-sur-Seine, France, Spedding Research Solutions SAS, Le Vesinet, France

  ⨯
• Thérèse M. Jay,

  Affiliations Laboratoire de Physiopathologie des Maladies Psychiatriques, UMR_S894 Inserm, Centre de Psychiatrie et Neurosciences, Paris, France, Université Paris Descartes, Sorbonne Paris Cité, Paris, France

  ⨯
• Bill P. Godsil

  * E-mail: bp.godsil@gmail.com

  Affiliations Laboratoire de Physiopathologie des Maladies Psychiatriques, UMR_S894 Inserm, Centre de Psychiatrie et Neurosciences, Paris, France, Université Paris Descartes, Sorbonne Paris Cité, Paris, France

  http://orcid.org/0000-0001-7248-4292

  ⨯